Want to see NSPR full AI Analyst Report?
InspireMD (NSPR) Ratios
InspireMD Ratios
NSPR's free cash flow for Q2 2026 was $-11.22M. For the 2026 fiscal year, NSPR's free cash flow was decreased by $-330.00K and operating cash flow was $-10.89M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.74 | 5.28 | 7.34 | 4.21 | 8.53 |
| Quick Ratio | 5.42 | 4.94 | 6.99 | 3.89 | 8.27 |
| Cash Ratio | 0.83 | 2.46 | 1.60 | 0.91 | 2.76 |
| Solvency Ratio | -3.40 | -2.96 | -2.42 | -2.52 | -2.39 |
| Operating Cash Flow Ratio | -3.28 | -2.85 | -2.72 | -3.07 | -3.04 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 47.27M | $ 29.80M | $ 36.02M | $ 14.07M | $ 30.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.05 | 0.03 | 0.07 | 0.03 |
| Debt-to-Equity Ratio | 0.06 | 0.06 | 0.04 | 0.09 | 0.04 |
| Debt-to-Capital Ratio | 0.06 | 0.06 | 0.04 | 0.08 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.30 | 1.21 | 1.42 | 1.18 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -92.99 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -93.73 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 0.06 | 0.07 | 0.21 | 0.18 |
| Net Debt to EBITDA | 0.12 | 0.52 | 0.38 | 0.16 | 0.74 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.50% | 21.49% | 29.12% | 21.60% | 16.77% |
| EBIT Margin | -542.63% | -455.79% | -340.74% | -361.88% | -327.39% |
| EBITDA Margin | -537.33% | -451.79% | -337.00% | -358.25% | -323.80% |
| Operating Profit Margin | -546.97% | -478.00% | -340.74% | -361.88% | -327.39% |
| Pretax Profit Margin | -542.63% | -455.79% | -319.92% | -357.05% | -330.88% |
| Net Profit Margin | -543.33% | -456.63% | -320.97% | -357.59% | -331.88% |
| Continuous Operations Profit Margin | -543.33% | -456.63% | -320.97% | -357.59% | -331.88% |
| Net Income Per EBT | 100.13% | 100.18% | 100.33% | 100.15% | 100.30% |
| EBT Per EBIT | 99.21% | 95.35% | 93.89% | 98.66% | 101.07% |
| Return on Assets (ROA) | -70.29% | -68.38% | -41.80% | -75.01% | -37.57% |
| Return on Equity (ROE) | -88.38% | -88.69% | -50.42% | -106.31% | -44.49% |
| Return on Capital Employed (ROCE) | -83.68% | -85.62% | -50.80% | -95.56% | -41.61% |
| Return on Invested Capital (ROIC) | -82.18% | -84.45% | -50.13% | -93.56% | -41.12% |
| Return on Tangible Assets | -70.29% | -68.38% | -41.80% | -75.01% | -37.57% |
| Earnings Yield | -37.31% | -29.02% | -29.21% | -273.13% | -67.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.50 | 3.11 | 2.53 | 4.15 | 3.24 |
| Payables Turnover | 5.04 | 4.39 | 4.68 | 6.15 | 4.19 |
| Inventory Turnover | 1.86 | 2.14 | 2.09 | 2.50 | 3.27 |
| Fixed Asset Turnover | 1.42 | 1.48 | 2.45 | 2.09 | 2.62 |
| Asset Turnover | 0.13 | 0.15 | 0.13 | 0.21 | 0.11 |
| Working Capital Turnover Ratio | 0.21 | 0.20 | 0.23 | 0.21 | 0.20 |
| Cash Conversion Cycle | 227.84 | 204.67 | 241.09 | 174.63 | 137.18 |
| Days of Sales Outstanding | 104.39 | 117.38 | 144.24 | 88.02 | 112.79 |
| Days of Inventory Outstanding | 195.82 | 170.46 | 174.78 | 145.95 | 111.52 |
| Days of Payables Outstanding | 72.37 | 83.17 | 77.93 | 59.33 | 87.13 |
| Operating Cycle | 300.21 | 287.84 | 319.02 | 233.97 | 224.31 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.48 | -0.52 | -0.67 | -1.97 | -1.80 |
| Free Cash Flow Per Share | -0.50 | -0.55 | -0.69 | -2.03 | -1.85 |
| Dividend Paid and CapEx Coverage Ratio | -21.12 | -15.60 | -42.98 | -32.86 | -38.40 |
| Capital Expenditure Coverage Ratio | -21.12 | -15.60 | -42.98 | -32.86 | -38.40 |
| Operating Cash Flow Coverage Ratio | -10.67 | -9.35 | -10.27 | -9.63 | -11.00 |
| Operating Cash Flow to Sales Ratio | -3.91 | -3.12 | -2.64 | -3.01 | -2.94 |
| Free Cash Flow Yield | -28.11% | -21.10% | -24.57% | -236.56% | -61.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.34 | -3.46 | -3.42 | -0.37 | -1.49 |
| Price-to-Sales (P/S) Ratio | 14.56 | 15.73 | 10.99 | 1.31 | 4.94 |
| Price-to-Book (P/B) Ratio | 2.37 | 3.06 | 1.73 | 0.39 | 0.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.56 | -4.74 | -4.07 | -0.42 | -1.64 |
| Price-to-Operating Cash Flow Ratio | -3.73 | -5.04 | -4.16 | -0.44 | -1.68 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.47 | 0.05 | -0.02 | 0.02 |
| Enterprise Value Multiple | -2.59 | -2.96 | -2.88 | -0.20 | -0.78 |
| Enterprise Value | 125.12M | 93.69M | 60.15M | 3.75M | 11.38M |
| EV to EBITDA | -2.59 | -2.96 | -2.88 | -0.20 | -0.78 |
| EV to Sales | 13.93 | 13.37 | 9.69 | 0.73 | 2.53 |
| EV to Free Cash Flow | -3.40 | -4.03 | -3.59 | -0.23 | -0.84 |
| EV to Operating Cash Flow | -3.56 | -4.28 | -3.67 | -0.24 | -0.86 |
| Tangible Book Value Per Share | 0.75 | 0.86 | 1.63 | 2.21 | 4.56 |
| Shareholders’ Equity Per Share | 0.75 | 0.86 | 1.63 | 2.21 | 4.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.12 | 0.17 | 0.26 | 0.66 | 0.61 |
| Net Income Per Share | -0.66 | -0.76 | -0.82 | -2.35 | -2.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.94 | 0.99 | 1.01 |
| Research & Development to Revenue | 1.67 | 1.95 | 1.29 | 1.51 | 1.15 |
| SG&A to Revenue | 4.15 | 3.05 | 1.79 | 1.62 | 1.65 |
| Stock-Based Compensation to Revenue | 1.37 | 1.45 | 0.72 | 0.45 | 0.35 |
| Income Quality | 0.72 | 0.68 | 0.82 | 0.84 | 0.89 |
Currency in USD
